Genomics and Proteomics Forays into Psychiatric Illness

The first genome-wide association study for genetic variations linked to bipolar disorder illustrates both the opportunities and the challenges of developing genomic and proteomic tests that can inform drug development and treatment of poorly understood psychiatric diseases.